Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.19.997890Source: DataRank Database

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

gen refseq pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Amy Sims ORCID,Shuntai Zhou ORCID,Rachel L. Graham ORCID,Collin S Hill ORCID,Sarah R. Leist ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3012210633

National Institutes of Health

Grant: 5R01AI108197-08

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

National Institutes of Health

Grant: 5U19AI109680-05

Antiviral Drug Discovery and Development Center - Overall

National Institutes of Health

Grant: 5R01AI132178-05

Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

National Institutes of Health

Grant: 5R01AI108197-10

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

National Institutes of Health

Grant: 5U19AI109680-03

Antiviral Drug Discovery and Development Center - Overall

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/03/20/2020.03.19.997890.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.03.19.997890

repositoryhttps://doi.org/10.1101/2020.03.19.997890

Europe_PMChttps://europepmc.org/article/PPR/PPR118100

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

VirologyIn vivoProdrugPotencyCoronavirusVero cellBiologyMiddle East respiratory syndrome coronavirusVirusOutbreakBioavailabilityPharmacologyIn vitroCoronavirus disease 2019 (COVID-19)MedicineDiseaseInfectious disease (medical specialty)Genetics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus

FAIR Checklist

Authors (24)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)